The Supreme Court closed the misleading advertisements case against Patanjali, observing that once manufacturing of a product is permitted, its advertisement becomes a natural business practice, providing relief to the company after months of legal scrutiny.
Today, On 7th March, The Supreme Court is set to issue comprehensive directions for enforcing the Drugs and Magic Remedies Act. The case stems from a writ petition by the Indian Medical Association (IMA). The IMA seeks action against misleading advertisements promoting allopathic medicines. The ruling aims to curb false medical claims and protect public health.
NEW DELHI: Today, 24th Feb, The Supreme Court of India strongly addressed the issue of misleading advertisements in the medical field, particularly those targeting allopathic medicine. The Court is hearing a plea filed by the Indian Medical Association (IMA) against such deceptive ads and has stressed the importance of following Rule 170 of the Drugs and Cosmetics Rules, 1945.
The Editors Guild of India (EGI) has expressed concerns to Union Home Minister Amit Shah about potential misuse of new criminal laws against journalists. They emphasize the need for additional safeguards and proposed a review of the laws to prevent frivolous prosecution. The Guild seeks protection of media freedom under the Indian Constitution and requests a meeting with Shah to address these issues.
![[Patanjali Row] After SC Order, Union Gov. Mandates Self-Declaration Certificate for Advertisers](https://i0.wp.com/lawchakra.in/wp-content/uploads/2024/06/MicrosoftTeams-image-46.png?resize=300%2C168&ssl=1)
The Union Government mandates a self-declaration certificate for advertisers as per a Supreme Court order, requiring it for all new ads starting June 18, 2024. The certificate ensures ad compliance with regulations and prevents misleading claims. Advertisers must upload the certificate via specified portals, with existing ads exempt from this requirement.